Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2025
Oct. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,495 $ 1,271
Short-term investments 14,534 18,653
Receivables 173
Prepaid expenses and other current assets 1,420 1,265
Total current assets 17,449 21,362
Operating lease right-of-use asset 202 229
Total assets 17,651 21,591
Current liabilities:    
Accounts payable 276 525
Accrued expenses 1,751 1,946
Operating lease liability, current 39 29
Total current liabilities 2,066 2,500
Operating lease liability, non-current 174 203
Total liabilities 2,240 2,703
Commitments and contingencies (Note 10)
Shareholders’ equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 32,822,109 and 32,196,862 shares issued and outstanding as of July 31, 2025 and October 31, 2024, respectively 328 322
Additional paid-in capital 265,249 260,432
Accumulated deficit (248,982) (240,750)
Treasury stock, 2,000 shares at cost as of October 31, 2024 (6)
Total shareholders’ equity 16,595 19,998
Noncontrolling interest (Note 2) (1,184) (1,110)
Total equity 15,411 18,888
Total liabilities and equity 17,651 21,591
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, value